Concepedia

Rosemary F. Lawrence-Henderson

RF

8

Publications

311

Citations

8

H-Index

2012

Active since

Affiliations

Pfizer (United States)(Current)

Quanterix (United States)

Rosemary F. Lawrence-Henderson is an author at Pfizer (United States) specializing in medicine, engineering, and biostatistics.

Top concepts

Publications per year

2012–2021

8

Publications

8

Pharmacokinetic, Biodistribution, and Biophysical Profiles of TNF Nanobodies Conjugated to Linear or Branched Poly(ethylene glycol)

Yulia Vugmeyster, Clifford Entrican, Alison Joyce et al. · Bioconjugate Chemistry · 2012 · 64 citations

, , +19

A Novel GUCY2C-CD3 T-Cell Engaging Bispecific Construct (PF-07062119) for the Treatment of Gastrointestinal Cancers

Divya Mathur, Adam R. Root, Bozena Bugaj‐Gaweda et al. · Clinical Cancer Research · 2020 · 60 citations · Full text

One Mouse, One Pharmacokinetic Profile: Quantitative Whole Blood Serial Sampling for Biotherapeutics

Alison Joyce, Mengmeng Wang, Rosemary F. Lawrence-Henderson et al. · Pharmaceutical Research · 2014 · 53 citations

, , +7

An Assessment of LRRK2 Serine 935 Phosphorylation in Human Peripheral Blood Mononuclear Cells in Idiopathic Parkinson’s Disease and G2019S LRRK2 Cohorts

Shalini Padmanabhan, Thomas A. Lanz, Donal Gorman et al. · Journal of Parkinson s Disease · 2020 · 48 citations · Full text

Bioanalytical platform comparison using a generic human IgG PK assay format

Beth Leary, Rosemary F. Lawrence-Henderson, Mireia Fernández Ocaña et al. · Journal of Immunological Methods · 2013 · 34 citations

, , +14

Rows per page

1–5 of 8